TNF and hepatocellular carcinoma: Based on the above-mentioned clinical evidence, which mainly refer to HCC of any etiology and not specifically to NAFLD-associated HCC, TNF-α may not be a suitable circulating biomarker for the early detection of HCC in cirrhotic patients, since its serum concentrations did not differ between cirrhotic patients with and without HCC.